Walgreens Boots Alliance (WBA) Given a $85.00 Price Target at Jefferies Group

Jefferies Group set a $85.00 price target on Walgreens Boots Alliance (NASDAQ:WBA) in a report released on Tuesday. The brokerage currently has a buy rating on the pharmacy operator’s stock. Jefferies Group also issued estimates for Walgreens Boots Alliance’s Q3 2018 earnings at $1.43 EPS, Q4 2018 earnings at $1.53 EPS, FY2018 earnings at $5.96 EPS and FY2019 earnings at $6.55 EPS.

Other research analysts have also recently issued research reports about the company. Needham & Company LLC reaffirmed a buy rating and set a $88.00 target price (up previously from $86.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, January 10th. Zacks Investment Research raised Walgreens Boots Alliance from a hold rating to a buy rating and set a $85.00 target price on the stock in a research note on Sunday, January 21st. ValuEngine raised Walgreens Boots Alliance from a hold rating to a buy rating in a research note on Thursday, January 4th. Robert W. Baird reaffirmed a buy rating and set a $82.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, January 4th. Finally, Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the company a buy rating in a research note on Wednesday, January 3rd. One investment analyst has rated the stock with a sell rating, ten have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average target price of $83.35.

How to Become a New Pot Stock Millionaire

Shares of NASDAQ WBA opened at $63.47 on Tuesday. The company has a current ratio of 0.90, a quick ratio of 0.45 and a debt-to-equity ratio of 0.44. Walgreens Boots Alliance has a 1-year low of $61.74 and a 1-year high of $87.79. The company has a market cap of $64,964.02, a price-to-earnings ratio of 12.45, a P/E/G ratio of 1.06 and a beta of 1.16.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Wednesday, March 28th. The pharmacy operator reported $1.73 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.18. The firm had revenue of $33.02 billion for the quarter, compared to analysts’ expectations of $32.20 billion. Walgreens Boots Alliance had a return on equity of 20.38% and a net margin of 3.33%. The company’s quarterly revenue was up 12.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.36 earnings per share. analysts predict that Walgreens Boots Alliance will post 5.95 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Monday, March 12th. Investors of record on Thursday, February 15th were issued a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.52%. Walgreens Boots Alliance’s payout ratio is 31.37%.

In other news, insider Stefano Pessina purchased 98,858 shares of the stock in a transaction that occurred on Monday, January 15th. The stock was purchased at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 14.80% of the stock is currently owned by insiders.

Institutional investors have recently bought and sold shares of the business. Zions Bancorporation lifted its holdings in Walgreens Boots Alliance by 983.3% during the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after buying an additional 1,239 shares during the period. Financial Advocates Investment Management purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth $125,000. Fieldpoint Private Securities LLC lifted its holdings in Walgreens Boots Alliance by 428.6% during the fourth quarter. Fieldpoint Private Securities LLC now owns 1,850 shares of the pharmacy operator’s stock worth $134,000 after buying an additional 1,500 shares during the period. Bristlecone Advisors LLC purchased a new stake in Walgreens Boots Alliance during the third quarter worth $135,000. Finally, Trustcore Financial Services LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth $155,000. Institutional investors own 60.94% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3338025/walgreens-boots-alliance-wba-given-a-85-00-price-target-at-jefferies-group.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

STMicroelectronics  Posts  Earnings Results, Beats Estimates By $0.01 EPS
STMicroelectronics Posts Earnings Results, Beats Estimates By $0.01 EPS
ChipMOS TECHNOLOGIES  Hits New 52-Week High and Low at $13.95
ChipMOS TECHNOLOGIES Hits New 52-Week High and Low at $13.95
Aileron Therapeutics  Reaches New 52-Week High and Low at $5.55
Aileron Therapeutics Reaches New 52-Week High and Low at $5.55
MyBit Token 1-Day Trading Volume Tops $7,505.00
MyBit Token 1-Day Trading Volume Tops $7,505.00
Pylon Network  Hits Market Capitalization of $2.86 Million
Pylon Network Hits Market Capitalization of $2.86 Million
Financial Analysis: H2O Innovation  vs. Cesca Therapeutics
Financial Analysis: H2O Innovation vs. Cesca Therapeutics


© 2006-2018 Ticker Report. Google+.